Immutep Health Care
Cancer Pharmaceuticals

$0.315 0.010 (3.28%)

High $0.32	Low $0.30	Trades 243	Turnover $627,825	Volume 2,012,212
30 June 2023 at 4:10pm

Market Cap (4-Aug) $70,738,624 (530th)	Close (30-Jun) $0.315 0 (0%)	Volume (30-Jun) 2,012,212	Shortsold (30-Jul) 44,449,535 (3.02%) (106th)
52w High $0.470	52w Low $0.028	P/E 7.20	EPS -0.04

Short Interest

ASIC data, 30 Jul 2026

% Shorted

3.02% 0.01

vs 3.02% prior report

Most Shorted Rank

106th

of 716 shorted ASX stocks

Peak Short

3.74%

Jul 2026

Days to Cover

2.7

at 50d avg vol

View full short position history →

	Subject
	IMM IMM Ann: New investigator-initiated ph2 trial in Soft Tissue Sarcoma
	1 (current) 2 3
	IMM IMM Ann: Appendix 4E & 2022 Full Year Statutory Accounts
	IMM IMM Ann: Japanese Patent Grant for efti, soluble LAG-3 with anti-PD-1
	IMM IMM Ann: TACTI-002 2nd line lung cancer data presented at 2022 WCLC
	IMM IMM Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	IMM IMM Ann: Notification of cessation of securities - IMM
	IMM IMM Ann: Immutep granted Japanese Patent for IMP761
	IMM IMM Ann: TACTI-002 lung cancer data to be presented at 2022 WCLC
	IMM IMM Ann: Immutep Investor Update
	IMM IMM Ann: Webcast slides for 1st line NSCLC data from TACTI-002 trial
	IMM IMM Ann: Positive ORR in 1st line NSCLC from ph 2 TACTI-002 trial
	IMM IMM Ann: Immutep webcast for TACTI-002 data presented at ASCO 2022
	IMM IMM Ann: Immutep announces publication of ASCO 2022 abstracts
	IMM IMM Ann: Immutep Corporate Presentation
	IMM IMM Ann: Immutep to Present at Investor Conferences
	IMM IMM Ann: Leading Oncologists appointed to Clinical Advisory Board
	IMM IMM Ann: New & significant data from AIPAC phase 2b trial in MBC
	IMM IMM Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	IMM IMM Ann: Immutep to announce new TACTI-002 data at ASCO 2022
	IMM IMM Ann: Change in substantial holding
	IMM IMM Ann: Efti with Keytruda shows encouraging activity in lung cancer
	IMM IMM Ann: Immutep announces publication of ELCC 2022 abstract
	IMM IMM Article: Immutep shares surge 8pc on FDA validation of its immune checkpoint
	IMM IMM Ann: Immutep to present Phase IIb breast cancer data at ESMO 2022
	IMM IMM Ann: Japanese patent granted for LAG-3 antibody LAG525
	IMM IMM Ann: Change in substantial holding
	IMM IMM Ann: Application for quotation of securities - IMM
	IMM IMM Ann: Immutep receives FDA feedback for Efti development in MBC
	IMM IMM Article: Why Immutep is Lucy Turnbull’s only ASX-listed company board role
	IMM IMM Ann: Initial Director's Interest Notice - Lucy Turnbull
	IMM IMM Ann: Proposed issue of securities - IMM
	IMM IMM Ann: Appointment of Non-Executive Director
	IMM IMM Ann: Immutep to Present at Healthcare Investor Conferences
	IMM IMM Ann: Half Yearly Report and Accounts
	IMM IMM Ann: Immutep to present new data from TACTI-002 at ELCC 2022
	IMM IMM Ann: Immutep Investor Update
	IMM IMM Ann: Australian Patent Granted for Efti with PD-1 Inhibitors
	IMM IMM Ann: Change in substantial holding
	IMM IMM Ann: Death of Director Grant Chamberlain
	IMM IMM Ann: Immutep to present at February Investor Conferences
	IMM IMM Ann: Immutep Quarterly Activities Report and Appendix 4C
	IMM IMM Ann: Change in substantial holding
	IMM IMM Ann: Immutep Advances IMP761 Manufacturing
	IMM IMM Ann: Change of Registered Office Address
	IMM IMM Ann: Amended Constitution
	IMM IMM Ann: Change in substantial holding
	IMM IMM Ann: Notification regarding unquoted securities - IMM
	IMM IMM Ann: Good safety reported from 1st five patients in INSIGHT-003
	IMM IMM Ann: Change of Director's Interest Notice - Dr. Howard
	IMM IMM Ann: Change of Director's Interest Notice - Mr Voigt

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Imugene

IMU

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

End of Day Prices

Date	Close	Volume	Change
04-Aug	$0.05	3,550,287	+0.00 (2.17%)
03-Aug	$0.05	2,940,611	0.00 (0.00%)
31-Jul	$0.05	2,758,273	0.00 (0.00%)
30-Jul	$0.05	7,305,934	0.00 (2.13%)
29-Jul	$0.05	2,167,778	0.00 (0.00%)
28-Jul	$0.05	25,866,235	0.00 (2.08%)
27-Jul	$0.05	4,965,061	0.00 (0.00%)
24-Jul	$0.05	14,492,733	0.00 (4.00%)
23-Jul	$0.05	3,003,770	0.00 (0.00%)
22-Jul	$0.05	16,763,215	+0.00 (2.04%)
21-Jul	$0.05	3,550,883	0.00 (2.00%)
20-Jul	$0.05	12,370,257	0.00 (0.00%)
17-Jul	$0.05	24,511,699	-0.20 (80.00%)
18-Sep	$0.25	826,810	+0.02 (8.70%)
12-Sep	$0.23	1,043,977	-0.01 (4.17%)
3 up, 6 down, and 6 flat days

Immutep Health Care
Cancer Pharmaceuticals

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

IMM Immutep Health Care Cancer Pharmaceuticals

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Immutep Health Care
Cancer Pharmaceuticals